US Patent Issued to Takeda Pharmaceutical on Oct. 28 for "Nucleic acids encoding FcRn-binding antibodies, pharmaceutical compositions thereof and methods of use thereof to make antibodies" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,575, issued on Oct. 28, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Nucleic acids encoding FcRn-binding antibodies, pharmaceutical compositions thereof and methods of use thereof to make antibodies" was invented by Daniel J. Sexton (Melrose, Mass.), Christopher TenHoor (Hopkinton, Mass.) and Malini Viswanathan (Acton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to antibodies that bind FcRn and methods of using these antibodies."

The patent was filed on July 6, 2023, under Application No. 18/347,626.

*For further information, including images, charts and tables, please visit: http://patft.uspto.go...